Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C53290
http://purl.obolibrary.org/obo/NCIT_C53290
|
|---|---|
| Preferred Name | MUC-1 Peptide Vaccine |
| Definitions |
A cancer vaccine comprised of a synthetic peptide derived from the mucin 1 (MUC1) antigen with potential antineoplastic activity. Upon administration, MUC1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the MUC1 antigen, resulting in decreased tumor growth. Overexpressed on many tumor cells, MUC1 antigen, a mammary-type apomucin, is a high-molecular-weight transmembrane glycoprotein.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A cancer vaccine comprised of a synthetic peptide derived from the mucin 1 (MUC1) antigen with potential antineoplastic activity. Upon administration, MUC1 peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells positive for the MUC1 antigen, resulting in decreased tumor growth. Overexpressed on many tumor cells, MUC1 antigen, a mammary-type apomucin, is a high-molecular-weight transmembrane glycoprotein. |
|---|---|
| prefLabel | MUC-1 Peptide Vaccine
|
| label | MUC-1 Peptide Vaccine
|
| PDQ_Closed_Trial_Search_ID | 458103
|
| code | C53290
|
| prefixIRI | NCIT:C53290
|
| in_subset | |
| Display_Name | MUC-1 Peptide Vaccine
|
| Preferred_Name | MUC-1 Peptide Vaccine
|
| Contributing_Source | CTRP
|
| NCI_Drug_Dictionary_ID | 458103
|
| Legacy Concept Name | MUC-1_Peptide_Vaccine
|
| type | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 458103
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| UMLS_CUI | C1711297
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |